Research

Cellular

JMV-449 induced noticeable dose-dependent insulin-releasing actions in BRIN-BD11 beta-cells.

JMV-449 may be a promising agent for enhancing insulin secretion in diabetes treatment.

StrongSupportsmedium confidence
JMV-449...induced noticeable dose-dependent insulin-releasing actions in BRIN-BD11 beta-cells.
Stephen L. Craig et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2021

Why this rating

Based on the study design involving direct assessment of beta-cell function.

Source

Comparison of independent and combined effects of the neurotensin receptor agonist, JMV-449, and incretin mimetics on pancreatic islet function, glucose homeostasis and appetite control

Stephen L. Craig et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2021

DOI 10.1016/j.bbagen.2021.129917

otherCited 4×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →